Avicanna (TSE:AVCN) has released an update.
Avicanna Inc., a global biopharmaceutical company, has successfully closed a non-brokered private placement, raising $800,010 through the sale of units priced at $0.30 each. The funds will support the company’s operational and developmental activities, including production, manufacturing, and research. Avicanna’s diverse portfolio spans medical cannabis products, a pharmaceutical pipeline, and active pharmaceutical ingredients, underpinning its international market presence.
For further insights into TSE:AVCN stock, check out TipRanks’ Stock Analysis page.
